If your child or adolescent is 2 to 17 years old and has JIA symptoms, they may be able to participate. Both males and females can participate. Your child’s doctor will be able to determine their eligibility.
If your child is eligible and enrolls in this clinical study, their participation will last approximately 44 weeks. Participants may stop participation in the study at any time. If your child participates, s/he may be eligible to enroll in a long-term maintenance extension study with the same investigational medication.
In this clinical study, the investigational medication will be available as a pill and a liquid taken orally (by mouth) twice a day.
The investigational medication is being developed to treat the symptoms of JIA.
No, all study medication and study-related medical care will be provided at no cost to you while your child is enrolled in the study. Qualified children and their parents/guardians may also be reimbursed for study related expenses.
For your convenience, a downloadable brochure is provided for you and your family to review and discuss the clinical trial further. Click the button below to download.